This content is only available to 2026 ASCRS Annual Meeting physician registrants
To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2026 Annual Meeting registration.
This filme reviews the scientific rationale and clinical use of topical losartan for corneal opacity. By blocking fibrotic signaling pathways, it promotes myofibroblast apoptosis and basement membrane repair. Evidence from experimental models and human cases shows its ability to prevent and reverse stromal fibrosis, offering a new option to restore corneal clarity.
